Ran Zheng
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Ran Zheng is currently an Independent Director at Caribou Biosciences, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Landmark Bio PBLLC from 2021 to 2025, Vice President-Development Supply Chain at Amgen, Inc., and Chief Technical Officer at Orchard Therapeutics Plc from 2019 to 2021.
Education includes graduate studies at the University of Minnesota and undergraduate studies at Beijing Forestry University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 24.09.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Vorstandsvorsitzender | 01.01.2025 |
| ORCHARD THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2021 |
| AMGEN INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Forestry University
Beijing Forestry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Landmark Bio PBLLC
Landmark Bio PBLLC BiotechnologyHealth Technology Manufactures and develops cell & gene therapy products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen